A randomized, double-blind, controlled dose finding study of NGX-4010 [capsaicin dermal patch] for the treatment of postherpetic neuralgia

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 18 Apr 2011

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Capsaicin (Primary)
Indications Neuropathic pain; Postherpetic neuralgia
Focus Therapeutic Use
Sponsors NeurogesX

Most Recent Events

16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
02 Sep 2010 Results of a planned pooled analysis of this trial and 3 other RCTs [700005976, 70005965 and 700014824] were presented at the 13th World Congress on Pain.
22 Jul 2010 Results were published in the Journal of Pain.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight